AstraZeneca vaccine can cause unusual clots 4:14
(CNN Spanish) ––
Spaniards under 60 years of age will stop receiving the AstraZeneca vaccine against covid-19 as of this Thursday.
This was announced by the Minister of Health, Carolina Darias, after analyzing the latest pronouncement of the European Medicines Agency (EMA, for its acronym in English), which confirmed the existence of a link between the administration of the vaccine and the appearance of rare blood clots.
The EU agency finds that the AstraZeneca vaccine can cause unusual blood clots;
the UK recommends that under 30s get other vaccinations
This decision will include a new revision on the age limit to receive the AstraZeneca vaccine in Spain, currently set at 65 years.
As Darias clarified, the Health Commission will rule on this Thursday.
This announcement will force the Autonomous Communities to restructure vaccination schedules.
In the Community of Madrid, for example, the regional authorities announced that they will cancel the appointments of the citizens summoned to receive the AstraZeneca vaccine this Thursday.
advertising
As detailed by the regional government, there are around 600 people including teachers, firefighters and other emergency personnel.
AstraZeneca pauses pediatric vaccine trial 0:25
For those under 60 who have already received the first dose of the vaccine, and who are missing the second, Darias clarified that the possibility of inoculating a dose of a different vaccine will be studied.
Or even not administer any more, he pointed out.
This has been the path of the AstraZeneca vaccine in Spain
Since the first doses of AstraZeneca arrived in Spain on February 6, its administration in the population has suffered several setbacks.
In the first weeks of use, the health authorities recommended inoculating it in the population under 55 years of age.
On March 24, after being suspended for a week and a half due to thromboembolic events in some Europeans who received a dose, the health authorities decided to resume its administration to people between 18 and 65 years old.
Here's what you need to know about the risk of blood clots and the AstraZeneca vaccine against covid-19
According to data from the Ministry of Health, Spain has received 3,232,200 doses of the AstraZenec vaccine as of April 7.
Of these, 2,154,772 have already been administered.
The inoculation was being carried out mainly in the general population.
Also in professionals who carry out essential activities, such as police officers and teachers, who are between 60 and 65 years old.
The EMA said Wednesday that a combination of unusual blood clots with low platelet counts should be included as a side effect of the vaccine.
But, he did not go so far as to recommend that its use be limited.
The benefits of the injection outweigh the risks and COVID-19 is a "very serious disease," the agency added.
The European regulator issued the conclusion after analyzing 86 cases of clots.
Of that number, 62 were from clots seen in the sinuses and 24 in the abdomen;
of these, 18 resulted in death.
More than 25 million people received the AstraZeneca vaccine in the European Union and the United Kingdom.
Ace
